Interventional Cardiology Devices – Market Insights – Middle East and South Africa

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the MESA IC device market will grow modestly through 2029, driven by the rising prevalence of CAD, expanding penetration of IC procedures, increasing health insurance coverage in some segments, and government initiatives to improve the accessibility and affordability of IC devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the MESA region across a 10-year period.

The MESA IC device market will be impacted by the COVID-19 pandemic in the early years of the forecast period.

What guidance or recommendations have been issued for IC procedures in the face of infection containment and self-isolation measures?

How will the pandemic impact clinical trials and product launches?

Several emerging devices that are about to be launched in the US or European market will likely enter the MESA market in the coming years.  

Which devices are anticipated to enter the MESA market over the forecast period?

How will the availability of these new devices impact the overall market?

The implementation of new medical device regulations in Turkey will result in more stringent regulatory requirements.

How are competitors expected to respond to the regulations and how will this affect small- and mid-sized emerging competitors in particular?

Will these regulations impact product launches and product improvements?

In several Middle Eastern countries, the PTCA Balloon catheter market will be significantly affected by device reuse.

In which countries is device reuse more prevalent? How will this trend affect unit sales and revenues?

How will this trend change going forward?

Table of contents